SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
42.715 EUR
-0.02 (-0.06%)
SHL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
In the past year SHL had a positive cash flow from operations.
In the past 5 years SHL has always been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.83%, SHL is doing good in the industry, outperforming 65.08% of the companies in the same industry.
SHL has a Return On Equity of 11.88%. This is in the better half of the industry: SHL outperforms 71.43% of its industry peers.
With a decent Return On Invested Capital value of 7.65%, SHL is doing good in the industry, outperforming 65.08% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 9.33%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.65% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
SHL has a better Profit Margin (9.17%) than 66.67% of its industry peers.
In the last couple of years the Profit Margin of SHL has remained more or less at the same level.
Looking at the Operating Margin, with a value of 13.53%, SHL is in the better half of the industry, outperforming 63.49% of the companies in the same industry.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
SHL has a worse Gross Margin (38.63%) than 77.78% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SHL is creating some value.
Compared to 1 year ago, SHL has more shares outstanding
The number of shares outstanding for SHL has been increased compared to 5 years ago.
SHL has a better debt/assets ratio than last year.
2.2 Solvency
SHL has an Altman-Z score of 2.00. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
SHL's Altman-Z score of 2.00 is in line compared to the rest of the industry. SHL outperforms 46.03% of its industry peers.
The Debt to FCF ratio of SHL is 5.45, which is a neutral value as it means it would take SHL, 5.45 years of fcf income to pay off all of its debts.
SHL's Debt to FCF ratio of 5.45 is in line compared to the rest of the industry. SHL outperforms 55.56% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that SHL is somewhat dependend on debt financing.
SHL has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: SHL underperforms 69.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 2 |
ROIC/WACC1.2
WACC6.36%
2.3 Liquidity
SHL has a Current Ratio of 1.11. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL's Current ratio of 1.11 is on the low side compared to the rest of the industry. SHL is outperformed by 71.43% of its industry peers.
SHL has a Quick Ratio of 1.11. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a worse Quick ratio (0.79) than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
Measured over the past years, SHL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.29% on average per year.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 4.53% in the last year.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.08% yearly.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.66% yearly.
The Revenue is expected to grow by 5.04% on average over the next years.
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y13.66%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.87, which indicates a rather expensive current valuation of SHL.
Based on the Price/Earnings ratio, SHL is valued cheaper than 85.71% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.15. SHL is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.74, SHL is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 69.84% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.12. SHL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.87 | ||
| Fwd PE | 16.74 |
4.2 Price Multiples
66.67% of the companies in the same industry are more expensive than SHL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.75 | ||
| EV/EBITDA | 13.49 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)2.63
PEG (5Y)1.58
EPS Next 2Y9.66%
EPS Next 3Y11.45%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.30%.
SHL's Dividend Yield is rather good when compared to the industry average which is at 2.22. SHL pays more dividend than 80.95% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
SHL pays out 49.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.72%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
FRA:SHL (11/28/2025, 10:52:21 AM)
42.715
-0.02 (-0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.18B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts82.96
Price Target57.22 (33.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-7.54%
PT rev (3m)-7.54%
EPS NQ rev (1m)-9.25%
EPS NQ rev (3m)-9.25%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.51%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.87 | ||
| Fwd PE | 16.74 | ||
| P/S | 2.06 | ||
| P/FCF | 17.75 | ||
| P/OCF | 13.64 | ||
| P/B | 2.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.49 |
EPS(TTM)2.39
EY5.6%
EPS(NY)2.55
Fwd EY5.97%
FCF(TTM)2.41
FCFY5.63%
OCF(TTM)3.13
OCFY7.33%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)2.63
PEG (5Y)1.58
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.65% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 43.54% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.23% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2 |
F-Score8
WACC6.36%
ROIC/WACC1.2
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y13.66%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year40.06%
EBIT Next 3Y18.71%
EBIT Next 5Y13.72%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 17.87 and the Price/Book (PB) ratio is 2.67.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.